PROJECT Due

Student's Name
Institution
Date
 Introduction
The drug policy of America has dramatically changed over more than a century due to

health crises, political changes, and changes to the economy. The American perception of drugs,

beginning with the prohibitionist policies of the early 20 th century, transitioning towards modern

debates centered on legalization, harm reduction, and “the war on drugs” is reflective of a deep-

rooted anxiety, rigid control, and the attempts at betterment. Understanding policy detail has

become paramount as the United States struggles with the issue of opioids alongside the

repercussions of decades worth of stringent drug laws. The purpose of this paper is to provide an

integrative summary of the over the years main developments, effects, and changes made in the

drug policies of the United States years while also evaluating international policies.

The Shift Toward Public Health-Oriented Drug Policies

focus to viewing it as a public health concern. This change demonstrates a growing awareness of how

counter policy one that does not seek to lower the rate of addiction through providing treatment is

damaging. Many cities and states are adopting newer methods for dealing with substance use, including

medication-assisted treatment, mental health treatment, and even dual diagnosis. As a result of the

COVID-19 pandemic, gaps in the structures of care for people with substance use disorders were brought

to light. Consequently, state and federal governments loosened regulations on telehealth for MAT,

broadening access to lifesaving treatments like buprenorphine. This not only improved access, but began

to shift the mindset regarding the treatment of addiction; moving away from viewing addiction through a

criminal scope towards a medical one.

Furthermore, Portugal, which decriminalized all drugs in 2001 and employed a strong health-

centered approach, possesses health lessons for the U.S. Managing and treating drug-dependent

individuals, instead of incarcerated them, resulted in fewer overdoses and better public health. These

foreign examples are informing policy debates in American cities seeking decriminalization, like Oregon
through Measure 110, that are trying similar policies.

Historical Drug Control in the U.S.

The origin of U.S. drug policies started with the Harrison Narcotics Tax Act of 1914, which

imposed federal restrictions on opiates and cocaine. The opiates and cocaine control policies shifted in the

United States with the 1970 Controlled Substances Act (CSA) which divided drugs into schedules based

upon their medical usefulness and potential abuse. These changes set the groundwork for the war on

drugs declared by President Nixon in 1971 and expanded under succeeding presidencies. These policies

led to the 1980s and 1990s surge in the 'war on drugs' where there was an increase in the implementation

of policies such as mandatory minimum sentences, zero-tolerance approaches and three-strikes laws.

These policies resulted in the expansion of the 'war on drugs’ in the 1980s and 1990s, which was

characterized by increases in mandatory minimum sentences, zero-tolerance policies, and three-strike

laws. All of these escalated the rate of incarceration in the US, which was already disproportionately

targeted towards Black and Latino communities. These changes were accompanied by an enduring social

belief that drug abuse and distribution would decrease as strict enforcement and harsh sentences were

meted out. In actuality, these policies did little to limit the availability of drugs and exacerbated existing

racial and social divides. The historical context also reflects the relationship between social control of

drug use and international relations. For example, American control over UN treaties concerning the

regulation of narcotics promoted adherence to prohibitionist policies at the global level, which severely

influenced domestic governance frameworks while disregarding local culture and public health initiatives.

Racial and Socioeconomic Disparities in Drug Enforcement

The United States has had issues with racial and social class discrimination alongside drug law

enforcement. Despite the usage of drugs being relatively uniform across different races in the country,

African American and Latinx individuals face higher rates of arrest, prosecution, and incarceration for

drug-related offenses. These patterns do not happen purely by chance; they have been the outcome of

decades worth of racially discriminative policing and legal frameworks aimed at authoritarian control
over lower class communities, while allowing wealthier, predominantly white ones to escape notice.

One striking example of the discriminatory enforcement of drug laws is the disparity in

sentencing crack and powder cocaine offenses, which was set at 100:1. Crack cocaine was associated with

Black communities, while powder cocaine was synonymous with white users who resided in suburban

areas. Even after reforms like the Fair Sentencing Act reduced the disparity to 18:1, the damage had

already been done: entire generations of Black Americans were imprisoned for nonviolent drug offenses.

Despite no significant difference in the number of drugs consumed by Black and white Americans, Black

Americans are almost six times more likely to be incarcerated for drug related crimes.

These socioeconomic inequalities are deepening the existing gaps in society. Residents in

impoverished areas tend to be victims of severe policing such as stop-and-frisk, raids, and sustained

watching. Such communities have fewer options when it comes to receiving a legal defense, drug

rehabilitation, or even healthcare. On the other hand, wealthier individuals who indulge in drug use do so

behind closed doors and, instead of facing penalties, have access to treatment or counseling services. This

situation leads to a binary system: one that aggressively criminalizes impoverished, Black communities,

and another that seamlessly erases the existence of affluent, white communities.

Drug related crime enforcement consequences run far beyond detention. These policies result in

unemployment, difficulty in finding housing, breaking of family ties and the obtaining of a criminal

record all contribute to severely restricting one’s prospects. Another major factor contributing to

homicide rates has been illegal drug use in urban Black neighborhoods, and the violence inherent to that

drug use. In addition, drug laws have not been effectively enforced in the sense that they have not

meaningfully reduced drug use or strengthened the drugs available to users or disrupted supply chains.

Harm Reduction and Scientific Advances

Despite barriers in public opinion, the outlasting impact of the War on Drugs still sits in the

commanding seat when it comes to policy and law enforcement focus. The nation's budget for drug

interdiction, border patrol, and domestic policing coast billions of dollars each year. Because of this

expenditure, critical pathways have already been forged. Billions have already been spent on combating
drug issues, law enforcement measures, and border control.

The adoption of the MORE Act (Marijuana Opportunity Reinvestment and Expungement Act) by

the congress serves to take small, yet stern, steps towards moving on from funding the War on Drugs.

With the purpose of federally decriminalizing cannabis and deeming its regulation unconstitutional

empowering tax-payers to shift currency from the punish state to societal development organizations –

enacting this will aid in coming closer to holistic recovery for the state. Acceptable signs are still to be

decided, portraying signs of further damage control rigorously coined by conservative authoritative

forces. Although it's clear these set structures will face fierce opposition.

In addition, Canada and Uruguay have federally legalized recreational cannabis. These countries

serve as models on how detractors, who are concerned that legalization will lead to increased youth

consumption and crime rates, can be rebutted due to the absence of such issues surfacing in these nations

post-legalization.

Harm Reduction and Scientific Advances

Harm reduction has become an important aspect in contemporary drug policies because it aims to

reduce the health, social, and legal issues associated with drugs instead of promoting complete abstinence.

This philosophy supports several policies that have been implemented over the past decade, including

supervised consumption sites, naloxone distribution programs, and fentanyl test strips.

Addiction is more understood now than ever, thanks to scientific advances, particularly in

neuroscience, which has shown that substance abuse disorders stem from chronic relapsing conditions of

the brain, not a flaw of character. This change greatly affects the approach towards public policy and

treatment. For example, policy and clinical practice strive towards adopting funding based on evidence

which includes contingency management, cognitive behavioral therapy, and pharmacologic treatments

like methadone, buprenorphine, and naltrexone.

Moreover, the FDA broadened the scope of accessible over-the-counter naloxone, and some

states are testing out initiatives to incorporate harm reduction services as part of emergency medical

services and within hospital care. These steps are fueling the already increasing attempts to integrate care
for addiction into primary healthcare.

Organized Crime and the Domestic Drug Trade

The focus on international cartel activity is quite concerning, but it does not fully cover the scope

of domestic drug trafficking networks which are equally important in America. Over the years, the rise of

synthetic opioids especially fentanyl has created nightmares for public health and law enforcement

bodies. Unlike past drug epidemics, today’s crises deal with substances that are extremely powerful,

simple to produce, and frequently transported through fragmented online marketplaces. As a result of

these changes, new enforcement strategies have emerged such as the targeting of digital advertising and

selling spaces, enhancement of border inspection technology, and greater inter-agency cooperation

between federal bodies like the DEA and CDC. On the other hand, critics of these strategies assert that

the abundant enforcement on the supply side of drugs draws too much attention from efforts aimed at

demand reduction and rehabilitation. The flux in drug shipping methods and technologies used requires

U.S. policies to shift towards ones that focus on proactive healthcare rather than militarized policing.

Moreover, corruption associated with drug money continues to erode the institutions of both producer and

consumer nations. U.S. policy should appreciate the holistic view of global drug markets and consider

incorporating development assistance, institutional change, as well as transnational harm minimization

approaches.

Political and Legislative Dynamics of Drug Reform

Political will is important for the adoption of a particular drug policy. In the past ten years, there

has been a slow but gradual bipartisan shift for reform. On one side, progressive politician have tried to

decriminalize drug use, while conservative states like Oklahoma and Montana have passed medical

marijuana legislation. Add to that, there is overwhelming support for 'drug use being a health issue, not a

crime,’ which indicates positive changes in public sentiment towards the policy.

Even though there are advancements on the federal and state level, progress is still lacking in
other parts of legislation. Public opinion is very supportive yet, reform of cannabis at the federal level is

not proceeding. There are also significant political and legal hurdles to harm reduction policies like safe

injection sites. Along with this, the opioid crisis that came about due to the pharmaceutical industry, has

resulted in legal action suing the industry for billions—yet they did very little legally, in terms of

accountability and structural change for the pillars of the industry.

In the future, advocacy, active participation from the public, and indeed research will be essential

for meaningful drug policy reform. Decision makers have to shift their focus to solutions based on health

and human rights. If other countries successfully shifting their drug policies in this direction demonstrates

that meaningful reform is both possible and effective strive to break boundaries then that’s a clear sign of

hope. These international policies showcase what US drug lawmakers need to do analytically and through

a social equity lens. Change for the country can happen now with the support of bipartisan individuals

and the public.

Conclusion

The past decade has seen transformative changes in U.S. drug policy. The country is beginning to

mitigate the damage induced by years of prohibition and mass incarceration, shifting from severe

enforcement to health-focused and evidence-based strategies. Nonetheless, there is still plenty of political

pushback, systemic inequities, and emerging public health threats that make the way forward difficult.

Policies surrounding drugs need to be just, equitable, and grounded in scientific methods so that reform

goes beyond the symbolic and becomes genuinely transformative. Countries that have more effective

policies offer lessons urgently advocating for a more well-rounded and humane approach to drug control.